Amryt Pharma PLC Company Profile (LON:FAST)

About Amryt Pharma PLC

Amryt Pharma PLC logoAmryt Pharma plc, formerly Fastnet Equity plc, is a United Kingdom-based specialty pharmaceutical company. The Company focuses on developing and delivering treatments for patients with rare and orphan diseases. The Company's products include Episalvan and Imlan. The Company's products focus on developing somatostatin analogue (SSA) peptide medicines for patients with rare neuroendocrine diseases, including acromegaly and Cushing's disease. The Company's Episalvan is a prescription pharmaceutical product, which accelerates wound healing. The Company's Episalvan consists of two ingredients, such as betulin-based active ingredient and sunflower oil as the excipient. The Company's Imlan products have regenerative and anti-inflammatory properties. Betulin is the active ingredient in the Imlan products and functions as the stabilizer of the creams and lotions. The Company's Imlan Creme Pur consists of Betulin, oil and water ingredients.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: LON
  • Symbol: FAST
  • CUSIP:
Key Metrics:
  • Previous Close: $0.04
  • 50 Day Moving Average: $2.91
  • 200 Day Moving Average: $2.54
  • 52-Week Range: GBX 1.85 - GBX 3.90
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $N/A
Additional Links:

Analyst Ratings

Consensus Ratings for Amryt Pharma PLC (LON:FAST) (?)
Ratings Breakdown: 1 Hold Rating
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: N/A

Analysts' Ratings History for Amryt Pharma PLC (LON:FAST)
DateFirmActionRatingPrice TargetDetails
2/7/2017Beaufort SecuritiesReiterated RatingSpeculative BuyView Rating Details
3/26/2015Davy ResearchReiterated RatingOutperformView Rating Details
(Data available from 2/24/2015 forward)


Earnings History for Amryt Pharma PLC (LON:FAST)
No earnings announcements for this company have been tracked by


Earnings Estimates for Amryt Pharma PLC (LON:FAST)
Current Year EPS Consensus Estimate: $-0.33 EPS


Dividend History for Amryt Pharma PLC (LON:FAST)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Amryt Pharma PLC (LON:FAST)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/3/2015Friel,CathalInsiderBuy3,555,394GBX 4£142,215.76
6/26/2015Friel,CathalInsiderBuy17,308,080GBX 0.04£6,923.23
(Data available from 1/1/2013 forward)


Latest Headlines for Amryt Pharma PLC (LON:FAST)
DateHeadline logoAmryt Pharma on the fast-track to commercial success (LON:FAST) - December 9 at 5:25 PM logoAmryt Pharma on the fast-track to commercial success - Proactive Investors UK (LON:FAST) - December 9 at 9:59 AM logoAmryt Pharma on the fast-track to being cash generative (LON:FAST) - December 5 at 11:41 AM
News IconAcromegaly - Pipeline Review, H2 2016 - New Market Research Report (LON:FAST) - November 15 at 5:29 PM logoAllergan to Host Third Quarter 2016 Earnings Conference Call and Webcast (LON:FAST) - October 13 at 4:57 PM logo"Abdominal Pain Global Clinical Trials Review, H2, 2016" Is Now Available at Fast Market Research (LON:FAST) - October 12 at 9:54 AM logoDump Horizon Pharma PLC (HZNP) Stock Now! Don’t Wait! (LON:FAST) - October 11 at 5:08 PM logoAmryt Has "Transformational" First Half As Lead Drug Gets US Patent (LON:FAST) - September 13 at 9:50 AM
News IconThis Marijuana Stock Has Big News on Tap (LON:FAST) - September 7 at 5:06 PM
News IconPharmaceutical giant opening new campus in N.J. (LON:FAST) - August 18 at 10:18 PM logoMerck, Pfizer Double Size of Diabetes Drug Study to Catch Rivals (LON:FAST) - June 11 at 10:23 PM logo"Chemotherapy Induced Nausea and Vomiting Global Clinical Trials Review, H1, 2016" Is Now Available (LON:FAST) - June 9 at 5:00 PM logoAmryt Pharma posts loss (LON:FAST) - June 9 at 7:59 AM logoAmryt Pharma Plans Trials Of Episalvan Product By End Of 2016 (LON:FAST) - June 9 at 7:59 AM logoAmryt Pharma excited by orphan diseases market (LON:FAST) - June 9 at 7:59 AM
News IconMateria, Inc. Introduces New Proxima Thermoset Resin Portfolio For The Oil And Gas Industry (LON:FAST) - June 7 at 5:04 PM logoDrug Delivery Technology Market Strategies and Forecasts, 2016 to 2026 (LON:FAST) - June 7 at 8:58 AM
News IconFDA Approves First-Of-Its-Kind Implant To Treat Opioid Addiction (LON:FAST) - June 7 at 8:58 AM logoChase Pharmaceuticals Continues to Build Its Senior Leadership Team with Appointment of Two Healthcare Industry Veterans (LON:FAST) - June 7 at 8:58 AM logoHalf Year 2016 Fastnet Equity PLC Earnings Release - Time Not Supplied (LON:FAST) - December 21 at 7:07 AM


What is Amryt Pharma PLC's stock symbol?

Amryt Pharma PLC trades on the London Stock Exchange (LON) under the ticker symbol "FAST."

How do I buy Amryt Pharma PLC stock?

Shares of Amryt Pharma PLC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

How much does a share of Amryt Pharma PLC stock cost?

One share of Amryt Pharma PLC stock can currently be purchased for approximately GBX 2.97.

Last Updated on 2/24/2017 by Staff